Gene · 6241
Papers4,414
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 4,414
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Single-cell RNA sequencing uncovers dynamic roadmap during chicken spermatogenesis. | BMC Genomics | 2025 | 40804371 | PubTator, text mining | PubMed |
| Multivalent interactions with CCR4-NOT and PABPC1 determine mRNA repression efficiency by tristetraprolin. | Nat Commun | 2025 | 40804313 | PubTator, text mining | PubMed |
| Integrative single-cell and bulk transcriptomic analyses identify a robust four-gene signature for risk stratification in neuroblastoma. | Transl Cancer Res | 2025 | 40792136 | PubTator, text mining | PubMed |
| Effect of arginine supplementation on liver and pectoral muscle: Tissue-specific lipid metabolism in broilers. | Poult Sci | 2025 | 40779811 | PubTator, text mining | PubMed |
| Identification of hub genes predicting sensitivity to neoadjuvant chemoradiation in locally advanced rectal cancer. | Radiol Oncol | 2025 | 40770782 | PubTator, text mining | PubMed |
| A newly developed ferroptosis-related gene signature for forecasting prognosis in uveal melanoma. | Methods | 2025 | 40763838 | PubTator, text mining | PubMed |
| RRM2-mediated inhibition of GPX4 ubiquitination: A novel mechanism for ferroptosis suppression and reduced cisplatin sensitivity in small cell lung cancer. | Cell Signal | 2025 | 40754122 | PubTator, text mining | PubMed |
| M6A modification of RRM2 drives B cell hyperactivity in primary Sjögren's syndrome. | Life Sci | 2025 | 40752678 | PubTator, text mining | PubMed |
| Emerging role of SETD2 in the development and function of immune cells. | Genes Dis | 2025 | 40746737 | PubTator, text mining | PubMed |
| IC2Bert: masked gene expression pretraining and supervised fine tuning for robust immune checkpoint blockade (ICB) response prediction. | Sci Rep | 2025 | 40745034 | PubTator, text mining | PubMed |
| Plasma proteomics-based risk scores for psoriasis prediction: a novel approach to early diagnosis. | Front Immunol | 2025 | 40735322 | PubTator, text mining | PubMed |
| Unraveling resistance mechanisms to the novel nucleoside analog RX-3117 in lung cancer: insights into DNA repair, cell cycle dysregulation and targeting PKMYT1 for improved therapy. | J Exp Clin Cancer Res | 2025 | 40702552 | PubTator, text mining | PubMed |
| Integration of scRNA-seq and ST-seq identifies hyperproliferative RRM2+ cells features and therapeutic targets in gastric cancer. | J Transl Med | 2025 | 40665360 | PubTator, text mining | PubMed |
| RRM2 regulates the high expression of PD-L1 via the ERK signaling pathway to play a cancer-promoting role in cervical cancer. | Pathol Res Pract | 2025 | 40651124 | PubTator, text mining | PubMed |
| Exploring the urate lowering properties of Erigeron annuus Lin. and phytosterol contributions: In vitro assays and in silico approaches. | Steroids | 2025 | 40645438 | PubTator, text mining | PubMed |
| MAGI2-AS3/miR-450b-5p/COLEC10 interaction network: A potential therapeutic and prognostic marker in hepatocellular carcinoma. | ILIVER | 2025 | 40636781 | PubTator, text mining | PubMed |
| CircASH1L inhibits ferroptosis and enhances cisplatin resistance by sponging miR-515-5p to regulate cell cycle-related CDCA7/RRM2 in ovarian cancer cells. | Front Pharmacol | 2025 | 40630134 | PubTator, text mining | PubMed |
| Tracing the evolutionary pathway of SARS-CoV-2 through RNA sequencing analysis. | Sci Rep | 2025 | 40615624 | PubTator, text mining | PubMed |
| Exploring the pathogenesis of extranodal natural killer/T cell lymphoma complicated With EBV via microarray data analysis. | Leuk Res | 2025 | 40591982 | PubTator, text mining | PubMed |
| Blockade of de novo dNTP biosynthesis pathway delays HIV-1 early life cycle kinetics and dynamics. | mBio | 2025 | 40586616 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6241/papers?page=9